| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.002 | 1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.0039 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |